Does brain natriuretic peptide interact with the immune system after cardiac transplantation?
Brain natriuretic peptide (BNP) is a marker of diagnosis and prognosis in patients with chronic heart failure. Stored in ventricular myocytes, it is released during ventricular stretch and increased transmural pressure. However, BNP behaves unusually after cardiac transplantation, with a failure to return to normal levels. This raises a question over whether other processes are involved in both its production and secretion. Several studies suggest BNP levels are associated with allograft rejection and coronary graft vasculopathy. Both of these processes have a single denominator in common, the activated immune system. This overview considers further evidence suggesting that BNP interacts with the immune system after cardiac transplantation.
Shaw
Steven M
SM
The Transplant Centre, North West Regional Cardiac and Transplant Unit, University Hospital of South Manchester, NHS Hospitals Foundation Trust, Manchester, United Kingdom. doctorshaw@doctors.org.uk
Fildes
James
J
Yonan
Nizar
N
Williams
Simon G
SG
D000818:Animals; D016207:Cytokines / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007107:Immune System / Q000276:immunology*; D007113:Immunity, Innate / Q000276:immunology; D020097:Natriuretic Peptide, Brain / Q000276:immunology*
D016207:Cytokines; D020097:Natriuretic Peptide, Brain